Press release from Companies: Resolutions of the Extraordinary General Meeting of Curasight A/S on 2 July 2024

Press release from Companies: Directed issues registered at the Danish Business Authority

Press release from Companies: Directed issues registered at the Danish Business Authority

Press release from Companies: Curasight to present at HC Andersen Capital

Press release from Companies: Notice of Extraordinary General Meeting

Press release from Companies: Notice of Extraordinary General Meeting

Press release from Companies: Curasight A/S resolves on directed issues and a loan facility

Press release from Companies: Curasight A/S resolves on directed issues and a loan facility

Press release from Companies: Curasight Announces Enrollment of First Patient in Phase 2 trial with uTRACE[®] in Prostate Cancer

Press release from Companies: Curasight Announces Enrollment of First Patient in Phase 2 trial with uTRACE[®] in Prostate Cancer

Reports: Interim report Q1 2024

Press release from Companies: Curasight announces approval of clinical trial application (CTA) for phase 2 trial with uTRACE[®] in prostate cancer patients